Glaukos says late-stage eye disease treatment shows lasting benefits after single dose

Glaukos said on Wednesday patients treated with its late-stage eye disease therapy maintained improvements ​in vision and corneal shape three years ‌after a single treatment for keratoconus, a disease...

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。